Targeting Pathogenic Mechanisms

Image by NCIImage by NCIIn the effort to identify a disease-modifying therapy for PD, significant research has focused on developing approaches that target the pathogenic mechanisms hypothesized to be responsible for the neurodegeneration and dysfunction observed in PD.  Approaches can focus on blocking degenerative processes or promoting neurotrophic processes.

Specific approaches include targeting dopamine metabolism, inflammation and immune responses, oxidative stress and mitochondrial dysfunction, apoptosis, excitotoxicity, and protein handling and aggregation.

 

07 Dec 2009
New findings published today in PNAS further support the role of PINK1 and parkin in mitochondrial quality control discussed by Dr. Chu in her post. Vives-Bauza et al. demonstrate that parkin, in a ... 
Hot Topics@SfN 2009
19 Oct 2009
In the poster "Secreted alpha-synuclein oligomers -- A new target for therapeutic intervention in Parkinson's Disease?, Dr. Karin Danzer et al reported that secreted alpha-synuclein oligomers are ... 
Hot Topics@SfN 2009
18 Oct 2009
Poster Title: CB2 prevents BBB leakage and peripheral immune cell infiltration and protects nigrostriatal dopaminergic neurons in the MPTP model of Parkinson’s disease ... 
The New England Journal of Medicine reports exciting results today regarding the ADAGIO trial for rasagiline (Azilect). A follow up to the previous TEMPO study (Arch Neurol 61:561-566, ... 
23 Sep 2009
Responses: 14
New research from Dr. Lorenz Studer and colleagues published this week in Nature harnesses the potential of patient-derived induced-pluripotent stem cells to model pathogenesis and treatment of ... 
19 Aug 2009
Just over a year ago, Iceland’s deCODE Genetics kicked off a new era in personalised genetics with the launch of a direct-to-consumer service dubbed deCODEme. ... 
02 Feb 2009
10 Jun 2009
This group aims to promote interactions, collaborations and the exchange of ideas of those members interested in developing or characterizing genetic disease models, particularly mouse models. ...